Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 23, 2022 - Issue 7-8
Submit an article Journal homepage
2,672
Views
4
CrossRef citations to date
0
Altmetric
Cognition

Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches

Corey T. McMillan1 Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USACorrespondence[email protected]
View further author information
,
Joanne Wuu2 Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USAView further author information
,
Katya Rascovsky1 Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USAView further author information
,
Stephanie Cosentino3 The Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY, USAView further author information
,
Murray Grossman1 Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USAORCID Iconhttps://orcid.org/0000-0002-7447-6218View further author information
ORCID Icon,
Lauren Elman1 Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USAView further author information
,
Colin Quinn1 Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USAORCID Iconhttps://orcid.org/0000-0003-0618-5854View further author information
ORCID Icon,
Luis Rosario1 Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USAView further author information
,
Jessica H. Stark2 Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USAView further author information
,
Volkan Granit2 Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USAView further author information
,
Hannah Briemberg4 Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, CanadaView further author information
,
Sneha Chenji5 Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, CanadaORCID Iconhttps://orcid.org/0000-0002-0635-1528View further author information
ORCID Icon,
Annie Dionne6 Department of Medicine, Université Laval, CanadaView further author information
,
Angela Genge7 Montreal Neurological Institute and Hospital, McGill University, Montreal, CanadaView further author information
,
Wendy Johnston10 Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada, andView further author information
,
Lawrence Korngut5 Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, CanadaView further author information
,
Christen Shoesmith8 London Health Sciences Centre, Western University, London, CanadaView further author information
,
Lorne Zinman9 Sunnybrook Health Sciences Centre, University of Toronto, Toronto, CanadaView further author information
, the Canadian ALS Neuroimaging Consortium (CALSNIC),
Sanjay Kalra10 Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada, and;11 Neuroscience and Mental Health Institute, University of Alberta, Edmonton, CanadaView further author information
&
Michael Benatar2 Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USAORCID Iconhttps://orcid.org/0000-0003-4241-5135View further author information
ORCID Icon show all
Pages 517-526 | Received 08 Jul 2021, Accepted 30 Jan 2022, Published online: 07 Mar 2022

References

  • Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
  • Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12:368–80.
  • Strong MJ, Abrahams S, Goldstein LH, et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:153–174.
  • Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, Wynne B, et al. Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology 2013;80:1590–7.
  • Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9–14.
  • Niven E, Newton J, Foley J, Colville S, Swingler R, Chandran S, et al. Validation of the Edinburgh cognitive and behavioural amyotrophic lateral sclerosis screen (ECAS): a cognitive tool for motor disorders. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:172–9.
  • De Icaza Valenzuela Mónica M, Bak TH, Suvankar P, Sharon A. The Edinburgh Cognitive and Behavioral ALS screen: relationship to age, education, IQ and the Addenbrooke’s Cognitive Examination-III. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:585–590.
  • Trojsi F, Caiazzo G, Siciliano M, Femiano C, Passaniti C, Russo A, et al. Microstructural correlates of Edinburgh Cognitive and Behavioural ALS Screen (ECAS) changes in amyotrophic lateral sclerosis. Psychiatry Res Neuroimaging. 2019;288:67–75.
  • Gregory JM, McDade K, Bak TH, et al. Executive, language and fluency dysfunction are markers of localised TDP-43 cerebral pathology in non-demented ALS. J Neurol Neurosurg Psychiatr. 2020;91:149–157.
  • Bakker LA, Schröder CD, Spreij LA, Verhaegen M, De Vocht J, Van Damme P, et al. Derivation of norms for the Dutch version of the Edinburgh cognitive and behavioral ALS screen. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:19–27.
  • Lulé D, Burkhardt C, Abdulla S, Böhm S, Kollewe K, Uttner I, et al. The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:16–23.
  • Mora JS, Salas T, Fernández MC, Rodríguez-Castillo V, Marín S, Chaverri D, et al. Spanish adaptation of the edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:74–9.
  • Poletti B, Solca F, Carelli L, Faini A, Madotto F, Lafronza A, et al. Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:387–95.
  • Loose M, Burkhardt C, Aho-Özhan H, Keller J, Abdulla S, Böhm S, et al. Age and education-matched cut-off scores for the revised German/Swiss-German version of ECAS. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:374–6.
  • Pinto-Grau M, Burke T, Lonergan K, McHugh C, Mays I, Madden C, et al. Screening for cognitive dysfunction in ALS: validation of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) using age and education adjusted normative data. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:99–106.
  • Kalra S, Khan MU, Barlow L, et al. The Canadian ALS Neuroimaging Consortium (CALSNIC) - a multicentre platform for standardized imaging and clinical studies in ALS. medRxiv 2020; 1–19. https://doi.org/10.1101/2020.07.10.20142679
  • Benatar M, Wuu J, Peng L. Reference data for commonly used sensory and motor nerve conduction studies. Muscle Nerve. 2009;40:772–94.
  • Muggeo VMR, Sciandra M, Tomasello A, Calvo S. Estimating growth charts via nonparametric quantile regression: a practical framework with application in ecology. Environ Ecol Stat. 2013;20:519–31.
  • Hodgins F, Mulhern S, Abrahams S. The clinical impact of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) and neuropsychological intervention in routine ALS care. Amyotroph Lateral Scler Frontotemporal Degener. 2019;12:1–8.
  • Placek K, Benatar M, Wuu J, Rampersaud E, Hennessy L, Van Deerlin VM, et al. Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis. EMBO Mol Med. 2021;13:e12595.
  • van den Berg LH, Sorenson E, Gronseth G, Macklin EA, Andrews J, Baloh RH, et al. Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials. Neurology 2019;92:e1610–e1623.
  • Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology2005;65:586–90.
  • Frank B, Haas J, Heinze HJ, Stark E, Münte TF. Relation of neuropsychological and magnetic resonance findings in amyotrophic lateral sclerosis: evidence for subgroups. Clin Neurol Neurosurg. 1997;99:79–86.
  • Ardila A. Toward the development of a cross-linguistic naming test. Arch Clin Neuropsychol. 2007;22:297–307.
  • Bates E, D'Amico S, Jacobsen T, Székely A, Andonova E, Devescovi A, et al. Timed picture naming in seven languages. Psychon Bull Rev. 2003;10:344–80.
  • Rosselli M, Ardila A, Salvatierra J, Marquez M, Matos L, Weekes VA. A cross-linguistic comparison of verbal fluency tests. Int J Neurosci. 2002;112:759–76.
  • Taylor LJ, Brown RG, Tsermentseli S, Al-Chalabi A, Shaw CE, Ellis CM, et al. Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatr. 2013;84:494–8.
  • Libon DJ, McMillan C, Avants B, Boller A, Morgan B, Burkholder L, et al. Deficits in concept formation in amyotrophic lateral sclerosis. Neuropsychology. 2012;26:422–9.
  • Ash S, Olm C, McMillan CT, Boller A, Irwin DJ, McCluskey L, et al. Deficits in sentence expression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:31–9.
  • Ash S, Menaged A, Olm C, McMillan CT, Boller A, Irwin DJ, et al. Narrative discourse deficits in amyotrophic lateral sclerosis. Neurology. 2014;83:520–8.
  • Nevler N, Ash S, McMillan C, Elman L, McCluskey L, Irwin DJ, et al. Automated analysis of natural speech in amyotrophic lateral sclerosis spectrum disorders. Neurology. 2020;95:e1629–e1639.
  • Knopman DS, Caselli RJ. Appraisal of cognition in preclinical Alzheimer's disease: a conceptual review. Neurodegener Dis Manag. 2012;2:183–95.
  • Brettschneider J, Libon DJ, Toledo JB, Xie SX, McCluskey L, Elman L, et al. Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis. Acta Neuropathol. 2012;123:395–407.
  • Stern Y. Cognitive reserve. Neuropsychologia. 2009;47:2015–28.
  • Lavrencic LM, Churches OF, Keage HAD. Cognitive reserve is not associated with improved performance in all cognitive domains. Appl Neuropsychol Adult. 2018;25:473–85.
  • Placek K, Massimo L, Olm C, Ternes K, Firn K, Van Deerlin V, et al. Cognitive reserve in frontotemporal degeneration: neuroanatomic and neuropsychological evidence. Neurology 2016;87:1813–9.
  • Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. 2018;91:e1370–e1380.
  • Crockford C, Newton J, Lonergan K, Madden C, Mays I, O'Sullivan M, et al. Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:65–73.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.